Greenphage
PrivateLast Round
Seed
Sep 15, 2025
Total Funding Raised
$2.53M
Company Overview
Greenphage is a biotechnology company that develops precision, biobased antibacterial solutions using bacteriophages to prevent infections and contamination in human, animal, and plant health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Water Treatment, Environmental Monitoring, Waste Management
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Greenphage Comparables
Compare Greenphage with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Phagelux AgriHealth | 78% | |
| Cytophage Technologies | 77% | |
| APS Biocontrol | 77% |
Greenphage Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 15, 2025 |
Greenphage Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sofilaro | Seed |
| GO Capital | Seed |
| IRDI Soridec Gestion | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 5, 2026
Grew 50% QoQ from 6 to 9 employees.
- Apr 6, 2026
Monthly visitors increased 3200% MoM.
Greenphage Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Greenphage's valuation, stock price, and market status.
Is Greenphage a public or private company?
Greenphage is a private company.
What is the current stock price of Greenphage?
Greenphage is a private company with no public stock price. Caplight tracks Greenphage's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Greenphage worth (valuation)?
Valuation information for Greenphage is not publicly available.
Can I buy Greenphage stock?
Greenphage shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Greenphage's last funding round?
Greenphage's most recent funding round was Seed on September 15, 2025.
Who are the main investors in Greenphage?
Key investors in Greenphage include Sofilaro, GO Capital, IRDI Soridec Gestion.
Will Greenphage IPO soon?
No public IPO plans have been announced for Greenphage.
How can I track Greenphage secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Greenphage's secondary market activity and sign up for updates.